Ilyang Pharmaceutical Co.,Ltd (007570.KS)
007570.KS Stock Price Chart
Explore Ilyang Pharmaceutical Co.,Ltd interactive price chart. Choose custom timeframes to analyze 007570.KS price movements and trends.
007570.KS Company Profile
Discover essential business fundamentals and corporate details for Ilyang Pharmaceutical Co.,Ltd (007570.KS) to support your stock research and investment decisions.
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
IPO Date
4 Jan 2000
Employees
637.00
Website
https://www.ilyang.co.krCEO
Dong-Yeon Kim
Description
Ilyang Pharmaceutical Co.,Ltd operates as a pharmaceutical company primarily in South Korea. The company offers anticancer, circulatory system, endocrine/metabolism, cheonjiyang, female hormone, urinary system, ophthalmology, liver disease, anti-inflammatory analgesic, digestive system, dermatology, respiratory system, nutrient infusion, and neurology medicines. It also provides antibiotics, antifungal drugs, anti-inflammatory analgesic drugs, insecticides, and vaccines; and health drinks, daily food, supplements, health food, cosmetics, and beverages. In addition, the company offers pharmaceutical raw materials products, such as aluminum hydroxide gel, dried aluminum hydroxide gel, magnesium hydroxide, magnesium hydroxide gel, aluminum hydroxide-magnesium carbonate co-dried gel, magnesium trisilicate, hydrotalcite, almagate, aluminum phosphate, aluminum phosphate gel, aluminum magnesium metasilicate, aluminum magnesium silicate, aluminum magnesium silicopolydrate, magaldrate, magaldrate wet gel, dihydroxy aluminum sodium carbonate, magnesium carbonate, aluminum magnesium hydroxide, synthetic aluminum silicate, and other products. Ilyang Pharmaceutical Co.,Ltd also exports its products to approximately 14 countries. The company was formerly known as Il-Yang Pharm. Ind. Co. and changed its name to Ilyang Pharmaceutical Co., Ltd. in May 1991. Ilyang Pharmaceutical Co.,Ltd was founded in 1946 and is headquartered in Yongin, South Korea.
007570.KS Financial Timeline
Browse a chronological timeline of Ilyang Pharmaceutical Co.,Ltd corporate events including earnings releases, dividend announcements, and stock splits.
Upcoming earnings on 13 May 2026
Upcoming earnings on 30 Jan 2026
Upcoming earnings on 12 Nov 2025
Earnings released on 12 Aug 2025
EPS came in at ₩32.10 , while revenue for the quarter reached ₩62.70B .
Earnings released on 15 May 2025
EPS came in at ₩196.98 , while revenue for the quarter reached ₩61.98B .
Earnings released on 1 Feb 2025
EPS came in at ₩205.10 , while revenue for the quarter reached ₩8.52B .
Dividend declared on 27 Dec 2024
A dividend of ₩150.00 per share was announced, adjusted to ₩150.00. The dividend was paid on 25 Apr 2025.
Earnings released on 15 Nov 2024
EPS came in at ₩192.00 , while revenue for the quarter reached ₩99.14B .
Earnings released on 14 Aug 2024
EPS came in at ₩60.42 , while revenue for the quarter reached ₩82.70B , beating expectations by +13.96%.
Earnings released on 16 May 2024
EPS came in at ₩112.61 , while revenue for the quarter reached ₩78.49B , beating expectations by +8.15%.
Earnings released on 22 Mar 2024
EPS came in at -₩410.62 , while revenue for the quarter reached ₩104.23B .
Dividend declared on 27 Dec 2023
A dividend of ₩150.00 per share was announced, adjusted to ₩150.00. The dividend was paid on 19 Apr 2024.
Earnings released on 15 Nov 2023
EPS came in at ₩268.87 , while revenue for the quarter reached ₩100.63B , beating expectations by +138.56K%.
Earnings released on 11 Aug 2023
EPS came in at -₩161.46 , while revenue for the quarter reached ₩85.36B , beating expectations by +17.61%.
Earnings released on 15 May 2023
EPS came in at ₩161.15 , while revenue for the quarter reached ₩80.32B , beating expectations by +10.67%.
Earnings released on 16 Mar 2023
EPS came in at ₩187.02 , while revenue for the quarter reached ₩101.12B , beating expectations by +139.23K%.
Dividend declared on 28 Dec 2022
A dividend of ₩150.00 per share was announced, adjusted to ₩150.00. The dividend was paid on 21 Apr 2023.
Earnings released on 30 Sept 2022
EPS came in at ₩635.24 , while revenue for the quarter reached ₩113.85B .
Earnings released on 30 Jun 2022
EPS came in at ₩394.90 , while revenue for the quarter reached ₩83.14B .
Earnings released on 31 Mar 2022
EPS came in at ₩533.51 , while revenue for the quarter reached ₩85.70B .
Earnings released on 31 Dec 2021
EPS came in at ₩172.33 , while revenue for the quarter reached ₩106.76B .
Dividend declared on 29 Dec 2021
A dividend of ₩200.00 per share was announced, adjusted to ₩200.00. The dividend was paid on 6 Apr 2022.
Earnings released on 11 Nov 2021
EPS came in at ₩170.00 , while revenue for the quarter reached ₩81.56B .
Earnings released on 30 Sept 2021
EPS came in at ₩424.00 , while revenue for the quarter reached ₩100.94B .
Earnings released on 31 Mar 2021
EPS came in at ₩22.00 , while revenue for the quarter reached ₩82.09B .
Earnings released on 31 Dec 2020
EPS came in at ₩17.55 , while revenue for the quarter reached ₩86.98B .
Dividend declared on 29 Dec 2020
A dividend of ₩120.00 per share was announced, adjusted to ₩120.00. The dividend was paid on 6 Apr 2021.
Earnings released on 30 Sept 2020
EPS came in at ₩269.00 , while revenue for the quarter reached ₩102.64B .
007570.KS Stock Performance
Access detailed 007570.KS performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.
Explore Related Stocks
Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.